US Patent No: 7,514,100

Number of patents in Portfolio can not be more than 2000

Controlled release hydrocodone formulations

3 Status Updates

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and controlled release material.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
PURDUE PHARMA L.P.STAMFORD, CT392

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Huang, Hua-Pin Englewood Cliffs, US 54 2054
Masselink, John K Old Tappan , US 24 616
Oshlack, Benjamin New York , US 215 10616
Tonelli, Alfred P Congers, US 15 726

Cited Art Landscape

Patent Info (Count) # Cites Year
 
PHARMACIA & UPJOHN AB (1)
5,614,218 Controlled release preparation 60 1994
 
Duphar International Research B.V. (1)
5,219,575 Compositions with controlled zero-order delivery rate and method of preparing these compositions 39 1990
 
RIJKSUNIVERSITEIT GRONINGEN (1)
4,708,874 Devices for the controlled release of active substances, as well as process for the preparation thereof 75 1986
 
DEUTSCHE BANK AG NEW YORK BRANCH (1)
4,983,730 Water soluble cellulose acetate composition having improved processability and tensile properties 79 1988
 
RICHARDSON-VICKS INC. (1)
4,996,047 Sustained release drug-resin complexes 113 1988
 
VALEANT INTERNATIONAL BERMUDA (1)
5,518,730 Biodegradable controlled release flash flow melt-spun delivery system 224 1992
 
ALZA CORPORATION (7)
5,019,397 Aqueous emulsion for pharmaceutical dosage form 106 1988
5,024,842 Annealed coats 96 1990
5,460,826 Morphine therapy 133 1994
6,491,945 Hydrocodone therapy 57 1994
5,593,695 Morphine therapy 75 1995
5,866,161 Hydrocodone therapy 72 1996
5,667,805 Morphine therapy 66 1996
 
ELAN CORPORATION, PLC (2)
4,609,542 New pharmaceutical forms for administration of medicaments by oral route, with programmed release 49 1985
5,637,320 Controlled absorption naproxen formulation for once-daily administration 64 1994
 
MERRELL DOW PHARMACEUTICALS INC. (1)
4,421,736 Sustained release diethylpropion compositions 77 1982
 
NIRO HOLDING A/S (1)
5,030,400 Process and an apparatus for agglomeration of a powdery material 81 1990
 
EURO-CELTIQUE S.A. (12)
4,443,428 Extended action controlled release compositions 139 1982
* 4,844,907 Pharmaceutical composition comprising analgesic and anti-inflammatory agent 151 1986
5,071,646 Pharmaceutical ion exchange resin composition 146 1989
5,356,467 Controlled release coatings derived from aqueous dispersions of zein 215 1993
5,500,227 Immediate release tablet cores of insoluble drugs having sustained-release coating 193 1993
5,670,172 Pharmaceutical spheroid formulation 99 1995
5,849,240 Method of preparing sustained release pharmaceutical compositions 173 1996
5,891,471 Pharmaceutical multiparticulates 152 1996
5,843,480 Controlled release diamorphine formulation 123 1996
5,879,705 Sustained release compositions of morphine and a method of preparing pharmaceutical compositions 159 1997
5,965,163 Substained release compositions and a method of preparing pharmaceutical compositions 163 1997
6,572,885 Orally administrable opioid formulations having extended duration of effect 103 2001
 
PURDUE PHARMA L.P. (25)
4,828,836 Controlled release pharmaceutical composition 219 1987
4,834,985 Controlled release pharmaceutical composition 231 1987
4,990,341 Controlled release hydromorphone composition 176 1989
5,266,331 Controlled release oxycodone compositions 246 1991
5,273,760 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer 257 1991
5,286,493 Stabilized controlled release formulations having acrylic polymer coating 253 1992
5,549,912 Controlled release oxycodone compositions 239 1993
5,472,712 Controlled-release formulations coated with aqueous dispersions of ethylcellulose 239 1993
5,580,578 Controlled release formulations coated with aqueous dispersions of acrylic polymers 222 1993
5,478,577 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level 250 1993
5,411,745 Powder-layered morphine sulfate formulations 156 1994
5,965,161 Extruded multi-particulates 187 1994
5,639,476 Controlled release formulations coated with aqueous dispersions of acrylic polymers 517 1995
5,508,042 Controlled release oxycodone compositions 259 1995
5,968,551 Orally administrable opioid formulations having extended duration of effect 258 1995
5,958,459 Opioid formulations having extended controlled released 169 1995
5,656,295 Controlled release oxycodone compositions 224 1996
5,681,585 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer 143 1996
5,672,360 Method of treating pain by administering 24 hour oral opioid formulations 236 1996
6,143,322 Method of treating humans with opioid formulations having extended controlled release 171 1997
5,958,452 Extruded orally administrable opioid formulations 221 1997
6,103,261 Opioid formulations having extended controlled release 164 1999
6,294,195 Orally administrable opioid formulations having extended duration of effect 151 1999
* 6,733,783 Controlled release hydrocodone formulations 160 2001
2004/0266,807 Controlled release hydrocodone formulations 66 2004
 
ASAHI KASEI CHEMICALS CORPORATION (1)
5,384,130 Spherical seed cores, spherical granules and process for production thereof 61 1993
 
VIRGINIA COMMONWEALTH UNIVERSITY (2)
5,321,012 Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance 178 1993
5,502,058 Method for the treatment of pain 158 1994
 
EUROCELTIQUE S.A., 122, BOULEVARD DE LA PETRUSSE, LUXEMBOURG (1)
4,844,909 Controlled release hydromorphone composition 168 1987
 
PFIZER INC. (1)
4,861,596 Rolled matrix device having enhanced ability to unroll and method for its production 27 1988
 
NIPPON SHINYAKU CO., LTD. (1)
5,456,923 Method of manufacturing solid dispersion 160 1993
 
TAKEDA PHARMACEUTICAL COMPANY LIMITED (1)
5,026,560 Spherical granules having core and their production 166 1988
 
GRUENENTHAL GMBH (1)
5,601,842 Sustained release drug formulation containing a tramadol salt 77 1996
 
ALPHARMA PHARMACEUTICALS, LLC (3)
5,202,128 Sustained release pharmaceutical composition 185 1990
5,330,766 Sustained release pharmaceutical composition 153 1993
5,378,474 Sustained release pharmaceutical composition 159 1993
 
CIBA-GEIGY CORPORATION (1)
4,548,990 Crosslinked, porous polymers for controlled drug delivery 135 1983
 
Hoechst Aktiengesellschaft (1)
4,935,246 Process for the coating of granules 124 1988
 
ARCHIMEDES DEVELOPMENT LIMITED (1)
5,629,011 Composition for nasal administration 92 1994
 
UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (1)
4,464,378 Method of administering narcotic antagonists and analgesics and novel dosage forms containing same 208 1981
 
DRUGTECH CORPORATION (2)
5,122,384 Oral once-per-day organic nitrate formulation which does not induce tolerance 50 1989
5,133,974 Extended release pharmaceutical formulations 303 1990
 
MILES INC. (1)
4,797,410 Suppression of withdrawal symptoms in opioid-induced tolerance or dependence 49 1987
 
FMC CORPORATION (3)
5,206,030 Film-forming composition and use for coating pharmaceuticals, foods and the like 63 1990
5,248,516 Film-forming composition: method of producing same and use for coating pharmaceuticals and foods and the like 51 1991
5,258,436 Film-forming composition; method of producing same and use for coating pharmaceuticals and foods and the like 41 1991
 
DepoMed Systems, Inc. (1)
5,007,790 Sustained-release oral drug dosage form 181 1989
 
GLATT GMBH (1)
5,132,142 Apparatus and method for producing pellets by layering power onto particles 69 1991
 
MERCK SHARP & DOHME CORP. (1)
4,377,568 Preparation of aqueous alcoholic dispersions of pH sensitive polymers and plasticizing agents and a method of enteric coating dosage forms using same 77 1981
 
GACELL LABORATORIES AB (3)
4,557,925 Membrane-coated sustained-release tablets and method 119 1984
5,178,868 Dosage form 72 1991
5,520,931 Controlled release morphine preparation 63 1995
 
Warner-Lambert Company (4)
4,483,847 Process for the manufacture of a pharmaceutical composition with a retarded liberation of active material 87 1983
4,600,645 Process for treating dosage forms 76 1985
5,068,110 Stabilization of enteric coated dosage form 77 1989
5,167,964 Semi-enteric drug delivery systems and methods for preparing same 91 1992
 
CADBURY ADAMS USA LLC (1)
4,894,234 Novel drug delivery system for antiarrhythmics 90 1988
 
FOREST LABORATORIES, INC. (1)
4,389,393 Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose 302 1982
 
PURDUE PHARMA COMPANY, THE (2)
4,861,598 Controlled release bases for pharmaceuticals 225 1986
4,970,075 Controlled release bases for pharmaceuticals 191 1989
 
FISONS CORPORATION (1)
4,959,219 Coating barriers comprising ethyl cellulose 49 1988
 
WATSON LABORATORIES, INC. (1)
4,806,337 Erodible matrix for sustained release bioactive composition 147 1986
 
ROHM GMBH (1)
4,520,172 Method for coating medicaments 59 1983
 
SPRING AG, PHARMAZEUTISCHE PRAEPARATE A SWISS CORP. (1)
5,292,461 Process for the production of pellets 74 1991
 
F.H. FAULDING & CO. LIMITED (1)
5,196,203 Theophylline dosage form 59 1991
 
AMERICAN CYANAMID COMPANY (1)
5,283,065 Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form 109 1992
 
PUREUE PHARMA L.P. (1)
4,834,984 Controlled release dihydrocodeine composition 161 1987
 
DUQUESNE UNIVERSITY OF THE HOLY GHOST, A CORP. OF PA. (1)
5,169,645 Directly compressible granules having improved flow properties 150 1989
 
ZYMA SA (1)
4,728,513 Granular delayed-release form of pharmaceutically active substances 83 1986
 
TCF NATIONAL BANK (1)
5,126,145 Controlled release tablet containing water soluble medicament 127 1990
 
Shionogi & Co., Ltd. (1)
5,023,089 Sustained-release preparations and the process thereof 66 1989
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
RECRO GAINESVILLE LLC (3)
9,132,096 Abuse resistant pharmaceutical compositions 1 2014
9,486,451 Abuse resistant pharmaceutical compositions 0 2015
9,452,163 Abuse resistant pharmaceutical compositions 0 2015
 
CIMA LABS INC. (3)
8,445,018 Abuse resistant drug formulation 18 2008
8,927,025 Alcohol-resistant metoprolol-containing extended-release oral dosage forms 1 2011
9,216,176 Abuse resistant drug formulation 0 2015
 
Pharmaceutical Manufacturing Research Services, Inc. (1)
9,492,444 Extruded extended release abuse deterrent pill 0 2014
 
EURO-CELTIQUE S.A. (1)
* 2004/0170,680 Once-a-day oxycodone formulations 95 2004
 
DEPOMED, INC. (8)
8,377,453 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic 12 2009
* 2010/0015,222 GASTRIC RETENTIVE EXTENDED-RELEASE DOSAGE FORMS COMPRISING COMBINATIONS OF A NON-OPIOID ANALGESIC AND AN OPIOID ANALGESIC 19 2009
9,161,911 Gastric retentive pharmaceutical compositions for treatment and prevention of CNS disorders 0 2009
* 2010/0040,689 GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR TREATMENT AND PREVENTION OF CNS DISORDERS 25 2009
8,372,432 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic 7 2009
* 2010/0196,474 Gastric Retentive Extended-Release Dosage Forms Comprising Combinations of a Non-Opioid Analgesic and an Opioid Analgesic 14 2009
8,394,408 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic 15 2012
8,668,929 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic 0 2012
 
SYNCHRONEURON INC. (3)
9,421,178 Acamprosate formulations, methods of using the same, and combinations comprising the same 0 2013
9,421,179 Acamprosate formulations, methods of using the same, and combinations comprising the same 0 2013
9,427,420 Acamprosate formulations, methods of using the same, and combinations comprising the same 0 2014
 
PURDUE PHARMA L.P. (20)
* 7,846,476 Once-a-day oxycodone formulations 38 2002
* 2011/0104,214 ONCE-A-DAY OXYCODONE FORMULATIONS 9 2010
8,980,291 Controlled release hydrocodone formulations 3 2010
* 8,551,520 Controlled release hydrocodone 23 2012
8,975,271 Controlled release hydrocodone formulations 0 2013
* 9,060,940 Controlled release hydrocodone 5 2014
8,975,273 Controlled release hydrocodone formulations 1 2014
8,951,555 Controlled release hydrocodone formulations 8 2014
9,023,401 Controlled release hydrocodone formulations 9 2014
9,056,052 Controlled release hydrocodone formulations 8 2015
9,056,107 Controlled release hydrocodone formulations 0 2015
9,320,717 Controlled release hydrocodone formulations 0 2015
9,278,074 Controlled release hydrocodone formulations 0 2015
9,289,391 Controlled release hydrocodone formulations 3 2015
9,205,055 Controlled release hydrocodone formulations 3 2015
9,205,056 Controlled release hydrocodone formulations 3 2015
9,198,863 Controlled release hydrocodone formulations 3 2015
9,526,724 Controlled release hydrocodone formulations 0 2016
9,517,236 Controlled release hydrocodone formulations 0 2016
9,504,681 Controlled release hydrocodone formulations 0 2016
 
LOCL PHARMA, INC. (8)
9,433,625 Pharmaceutical compositions for treating or preventing pain 0 2014
9,427,407 Pharmaceutical compositions 0 2015
9,402,813 Pharmaceutical compositions 1 2015
9,399,022 Pharmaceutical compositions 1 2015
9,393,207 Pharmaceutical compositions 1 2015
9,498,444 Pharmaceutical compositions 0 2015
9,387,177 Pharmaceutical compositions 0 2015
9,526,704 Pharmaceutical compositions for treating or preventing pain 0 2016
 
MALLINCKRODT INC. (9)
9,198,861 Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans 0 2011
8,597,681 Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans 13 2011
9,050,335 Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia 3 2012
8,858,963 Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia 3 2012
8,741,885 Gastric retentive extended release pharmaceutical compositions 3 2012
8,658,631 Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia 5 2012
9,433,582 Gastric retentive extended release pharmaceutical compositions 0 2014
9,539,328 Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia 0 2014
9,468,636 Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia 0 2015
 
EGALET LTD. (7)
8,877,241 Morphine controlled release system 2 2004
9,005,660 Immediate release composition resistant to abuse by intake of alcohol 2 2010
9,023,394 Formulations and methods for the controlled release of active drug substances 1 2013
8,808,745 Morphine polymer release system 5 2013
9,044,402 Abuse-deterrent pharmaceutical compositions for controlled release 1 2014
9,375,428 Morphine controlled release system 0 2014
9,358,295 Immediate release composition resistant to abuse by intake of alcohol 1 2015
* Cited By Examiner

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 7, 2016
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 7, 2020
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00